Published in Obesity and Diabetes Week, March 13th, 2006
This is the first study of bicifadine in patients with neuropathic pain. The trial is a randomized, multiple-dose, open-label, 2-phase overlap trial designed to assess the efficacy and safety of bicifadine and potential interactions of bicifadine and oxycodone used concurrently. DOV expects to complete dosing in the third quarter of this year.
The clinical trial will randomize 50 patients with painful diabetic neuropathy into 2 parallel 4-week treatment groups. In...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week